Table 2.
Socio-demographic characteristics of the study participants (n = 129).
| Characteristic | Category | Mean (±SD) | Range |
|---|---|---|---|
| Age (years) | 61.1 (±15.4) | 18–88 | |
| Time since diagnosis (years) | 3.7 (±4.3) | 0.05–23 | |
| n | % | ||
| Sex | Male | 76 | 58.9 |
| Female | 53 | 41.1 | |
| Employment status | Employed full time | 31 | 24.0 |
| Unemployed | 6 | 4.7 | |
| Self-employed | 8 | 6.2 | |
| Homemaker | 2 | 1.6 | |
| Retired | 71 | 55.0 | |
| Other | 4 | 3.1 | |
| Unknown | 5 | 3.9 | |
| Student | 2 | 1.6 | |
| Ethnic origin | White | 122 | 94.6 |
| Asian or Asian British | 1 | 0.8 | |
| Black or Black British | 6 | 4.7 | |
| Disease sub-type | AML | 18 | 14.0 |
| ALL | 7 | 5.4 | |
| CLL | 11 | 8.5 | |
| MM | 21 | 16.3 | |
| ANHL | 17 | 13.2 | |
| INHL | 14 | 10.9 | |
| CML | 12 | 9.3 | |
| MPN | 10 | 7.8 | |
| MDS | 8 | 6.2 | |
| HL | 11 | 8.5 | |
| Disease state | Stable | 34 | 26.4 |
| Progression | 49 | 38.0 | |
| Remission | 46 | 35.7 | |
| Comorbidities | Comorbidities, cases | 45 | 34.8 |
| Other Cancer, cases | 5 | 3.8 |
ALL, acute lymphoblastic leukaemia, AML, acute myeloid leukaemia ANHL, aggressive non-Hodgkin lymphoma; CLL, chronic lymphoid leukaemia; CML, chronic lymphoid leukaemia; HL, Hodgkin lymphoma; INHL, indolent non-Hodgkin lymphoma; MDS, myelodysplastic syndromes; MM, multiple myeloma; MPN, myeloproliferative neoplasm; SD, standard deviation.